IP Library › Granted Patent US 10,499,682
Granted Patent B2
US 10,499,682 · App. 14/756,311 · Granted Dec 10, 2019

Micronutrient formulation in electronic cigarettes

Inventors: Kedar Prasad (San Rafael, CA); Gerald Haase (Greenwood Village, CO)
Assignee: New Age Beverage Corporation
A24B15/16A24F47/002A61K9/007A61K9/0053A61K31/05A61K31/215A61K31/355A61K36/82
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,499,682
App. No.
14/756,311
Granted
Dec 10, 2019
Kind
B2
Abstract

An antioxidant formulation for use with electronic cigarettes is provided and the formulation comprises: Vitamin A, Vitamin E, Trans-Resveratrol, polyphenol, and tertiary butyl hydroquinone.

Claims (34)

1. An e-cigarette cartridge containing an atomizable liquid composition comprising Vitamin A, Vitamin E, trans-resveratrol, a green tea polyphenol, and tert-butylhydroquinone, wherein the atomizable liquid composition is nicotine free.

2. The e-cigarette cartridge of claim 1 , wherein the Vitamin A is retinyl palmitate.

3. The e-cigarette cartridge of claim 2 , wherein the amount of retinyl palmitate in the atomizable liquid composition is from 20 IU to 3,000 IU.

4. The e-cigarette cartridge of claim 1 , wherein the Vitamin E is d-alpha-tocopheryl acetate.

5. The e-cigarette cartridge of claim 4 , wherein the amount of d-alpha-tocopheryl acetate in the atomizable liquid composition is from 0.5 IU to 50 IU.

6. The e-cigarette cartridge of claim 1 , wherein the Vitamin E is d-alpha-tocopheryl succinate.

7. The e-cigarette cartridge of claim 6 , wherein the amount of d-alpha-tocopheryl succinate in the atomizable liquid composition is from 0.5 IU to 50 IU.

8. The e-cigarette cartridge of claim 1 , wherein the Vitamin E is a mixture of d-alpha-tocopheryl acetate and d-alpha-tocopheryl succinate.

9. The e-cigarette cartridge of claim 1 , wherein the amount of trans-resveratrol in the atomizable liquid composition is from 1 mg to 100 mg.

10. The e-cigarette cartridge of claim 1 , wherein the amount of green tea polyphenol in the atomizable liquid composition is from 1 mg to 100 mg.

11. The e-cigarette cartridge of claim 1 , wherein the amount of tert-butylhydroquinone in the atomizable liquid composition is from 0.5 mg to 20 mg.

12. An e-cigarette cartridge containing an atomizable liquid composition comprising:

retinyl palmitate;

d-alpha-tocopheryl acetate;

d-alpha-tocopheryl succinate;

trans-resveratrol;

a green tea polyphenol; and

tert-butylhydroquinone; and

wherein the atomizable liquid composition is nicotine free.

13. The e-cigarette cartridge of claim 12 , wherein the amount of retinyl palmitate in the atomizable liquid composition is from 20 IU to 3,000 IU.

14. The e-cigarette cartridge of claim 12 , wherein the amount of d-alpha-tocopheryl acetate in the atomizable liquid composition is from 0.5 IU to 50 IU.

15. The e-cigarette cartridge of claim 12 , wherein the amount of d-alpha-tocopheryl succinate in the atomizable liquid composition is from 0.5 IU to 50 IU.

16. The e-cigarette cartridge of claim 12 , wherein the amount of trans-resveratrol in the atomizable liquid composition is from 1 mg to 100 mg.

17. The e-cigarette cartridge of claim 12 , wherein the amount of green tea polyphenol in the atomizable liquid composition is from 1 mg to 100 mg.

18. The e-cigarette cartridge of claim 12 , wherein the amount of tert-butylhydroquinone in the atomizable liquid composition is from 0.5 mg to 20 mg.

19. An e-cigarette cartridge containing an atomizable liquid composition comprising:

retinyl palmitate, wherein the amount of retinyl palmitate in the atomizable liquid composition is from 20 IU to 3,000 IU;

d-alpha-tocopheryl acetate, wherein the amount of d-alpha-tocopheryl acetate in the atomizable liquid composition is from 0.5 IU to 50 IU;

d-alpha-tocopheryl succinate, wherein the amount of d-alpha-tocopheryl succinate in the atomizable liquid composition is from 0.5 IU to 50 IU;

trans-resveratrol, wherein the amount of trans-resveratrol in the atomizable liquid composition is from 1 mg to 100 mg;

a green tea polyphenol; and

tert-butylhydroquinone, wherein the amount of tert-butylhydroquinone in the atomizable liquid composition is from 0.5 mg to 20 mg; and

wherein the atomizable liquid composition is nicotine free.

20. The e-cigarette cartridge of claim 19 , wherein the amount of green tea polyphenol in the atomizable liquid composition is from 1 mg to 100 mg.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2022
From: JGB COLLATERAL, LLC
To: NABC, INC.
Reel/Frame 059383/0122 →
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2020
From: EAST WEST BANK
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
Reel/Frame 054733/0587 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2020
From: EAST WEST BANK
To: NEWAGE, INC.; NABC, INC.; MORINDA, INC.
Reel/Frame 054560/0232 →
SECURITY INTEREST Recorded Dec 1, 2020
From: ARIEL MERGER SUB 2, LLC; NEWAGE, INC. (A WASHINGTON CORPORATION); NABC, INC.; MORINDA, INC.
To: JGB COLLATERAL, LLC (A DELAWARE LIMITED LIABILITY COMPANY)
Reel/Frame 054509/0837 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2019
From: SIENA LENDING GROUP LLC
To: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 048752/0034 →
SECURITY INTEREST Recorded Apr 1, 2019
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES, INC.; MORINDA, INC.
To: EAST WEST BANK
Reel/Frame 048752/0082 →
SECURITY INTEREST Recorded Aug 13, 2018
From: NEW AGE BEVERAGES CORPORATION; NEW AGE HEALTH SCIENCES CORPORATION
To: SIENA LENDING GROUP LLC
Reel/Frame 046623/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2018
From: PREMIER MICRONUTRIENT CORPORATION
To: NEW AGE HEALTH SCIENCES, INC.
Reel/Frame 046599/0450 →